American Family Care Achieves Historic Franchise 500® Ranking

Nation's Largest Urgent Care Provider Ranks in Top 50 Franchises for the First Time American Family Care(AFC), the nation's leading provider of urgent care with nearly 400 walk-in clinics across the United States, is proud to announce that it is nowranked No. 47 on Entrepreneur's annual Franchise 500® list. This milestone marks the first time […]

Zight Launches System Audio and Smart Actions: Seamless Meeting Recording and AI-Powered Productivity

From Video to Documentation: Zight's New Features Automate SOPs, Bug Reports, and How-To Guides with AI Precision Zight, a pioneer in AI-drivenproductivity tools, proudly announces the launch ofSystem AudioandSmart Actions, two transformative features designed to elevate workflows and collaboration. Launching on January 22, 2025, these tools make Zight a comprehensive, all-in-one platform capable of replacing

New Financial Resilience Index Finds Cost Pressures Easing but Still Weighing on American Middle Class

Middle-class households are still adjusting to higher cost of living, while income growth and strong stock market bolster wealth and retirement savings, finds January 2025 Index The American Council of Life Insurers (ACLI) today released its January 2025 Financial Resilience Index measuring middle-class households' ability to manage financial challenges and plan for a stable future.

KUBTEC Awarded Tumor Localization Equipment and Related Accessories Category Agreement with Premier, Inc.

CONTACT:Richard WheltonHead / Director of Marketing, KUBTECrwhelton@kubtec.com(203) 364-8544 ext. 127 KUBTEC has been awarded a national group purchasing agreement for GammaPRO with Premier, Inc. Effective Jan 1, 2025., this new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for KUBTEC's GammaPRO gamma detection system. “This

Tennessee State Board of Education Approves Savvas Learning Company’s K-12 Science Solutions For Statewide Adoption For Every Grade Level

Savvas Learning Company, a next-generation K-12 learning solutions leader, is pleased to announce that the Tennessee State Board of Education has approved its evidence-based, standards-aligned K-12 science programs for statewide adoption. https://mma.prnewswire.com/media/2603163/CorWeb581F1220JW2_PR_Assets_TN_K_12_Science.jpg Savvas science programs are aligned to the new Tennessee Academic Standards for Science, which require science curricula to be “academically rigorous, relevant to

Forum 30: Advancing Global Standards for Medical Products of Human Origin

The International Council for Commonality in Blood Banking Automation (“ICCBBA”), in partnership with the Italian national competent authority for blood Centro Nazionale Sangue (“CNS”) and for cells/tissues Centro Nazionale Trapianti (“CNT”), hosted Forum 30 The MPHO Safety and Traceability Summit on 14-15 November 2024. The event convened over 100 health professionals, patients, regulators, and other

Shareholders that Lost Money on Marqeta, Inc. (MQ) Should Contact Levi & Korsinsky About Pending Class Action – MQ

NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Marqeta, Inc. (NASDAQ:MQ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/marqeta-inc-lawsuit-submission-form?prid=124382&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Verisk Estimates Industry Insured Losses for the Palisades and Eaton Fires Will Fall Between USD 28 Billion and USD 35 Billion

(NASDAQ:VRSK), BOSTON, Jan. 22, 2025 (GLOBE NEWSWIRE) — The Extreme Event Solutions group at Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider, estimates that insured industry losses to property for the Palisades and Eaton fires together will fall between USD 28 billion and USD 35 billion. This estimate includes losses due to

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Keros Therapeutics, Inc. – KROS

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Keros Therapeutics, Inc. ("Keros" or the "Company") (NASDAQ:KROS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Keros and certain of its officers and/or directors

Scroll to Top